Follow
Trudie Lang
Trudie Lang
Professor
Verified email at ndm.ox.ac.uk
Title
Cited by
Cited by
Year
Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised …
S Rts
Lancet 386 (9988), 31-45, 2015
2176*2015
Mortality after fluid bolus in African children with severe infection
K Maitland, S Kiguli, RO Opoka, C Engoru, P Olupot-Olupot, SO Akech, ...
New England Journal of Medicine 364 (26), 2483-2495, 2011
17912011
Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age
P Bejon, J Lusingu, A Olotu, A Leach, M Lievens, J Vekemans, S Mshamu, ...
New England Journal of Medicine 359 (24), 2521-2532, 2008
5252008
Health research capacity development in low and middle income countries: reality or rhetoric? A systematic meta-narrative review of the qualitative literature
SRP Franzen, C Chandler, T Lang
BMJ open 7 (1), e012332, 2017
2912017
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa
T Hawkridge, TJ Scriba, S Gelderbloem, E Smit, M Tameris, S Moyo, ...
The Journal of infectious diseases 198 (4), 544-552, 2008
2202008
Efficacy of RTS, S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a …
A Olotu, J Lusingu, A Leach, M Lievens, J Vekemans, S Msham, T Lang, ...
The Lancet infectious diseases 11 (2), 102-109, 2011
2162011
Experimental treatment of Ebola virus disease with TKM-130803: a single-arm phase 2 clinical trial
J Dunning, F Sahr, A Rojek, F Gannon, G Carson, B Idriss, T Massaquoi, ...
PLoS medicine 13 (4), e1001997, 2016
1902016
A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya
P Bejon, J Mwacharo, O Kai, T Mwangi, P Milligan, S Todryk, S Keating, ...
PLoS clinical trials 1 (6), e29, 2006
1822006
Clinical trials have gone global: is this a good thing?
T Lang, S Siribaddana
PLoS medicine 9 (6), e1001228, 2012
1562012
Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised …
A Alloueche, W Bailey, S Barton, J Bwika, P Chimpeni, CO Falade, ...
The Lancet 363 (9424), 1843-1848, 2004
1232004
The induction and persistence of T cell IFN-γ responses after vaccination or natural exposure is suppressed by Plasmodium falciparum
P Bejon, J Mwacharo, O Kai, S Todryk, S Keating, B Lowe, T Lang, ...
The Journal of Immunology 179 (6), 4193-4201, 2007
1102007
Advancing global health research through digital technology and sharing data
T Lang
Science 331 (6018), 714-717, 2011
1062011
Open source clinical science for emerging infections
JW Dunning, L Merson, GGU Rohde, Z Gao, MG Semple, D Tran, ...
The Lancet Infectious Diseases 14 (1), 8-9, 2014
1022014
Experimental treatment of Ebola virus disease with brincidofovir
J Dunning, SB Kennedy, A Antierens, J Whitehead, I Ciglenecki, ...
PloS one 11 (9), e0162199, 2016
1012016
Clinical research in resource-limited settings: enhancing research capacity and working together to make trials less complicated
TA Lang, NJ White, TT Hien, JJ Farrar, NPJ Day, R Fitzpatrick, BJ Angus, ...
PLoS neglected tropical diseases 4 (6), e619, 2010
1012010
The development of Lapdap, an affordable new treatment for malaria
T Lang, B Greenwood
The Lancet infectious diseases 3 (3), 162-168, 2003
942003
Use of deferred consent for severely ill children in a multi-centre phase III trial
K Maitland, S Molyneux, M Boga, S Kiguli, T Lang
Trials 12, 1-6, 2011
902011
The challenges and opportunities of conducting a clinical trial in a low resource setting: the case of the Cameroon mobile phone SMS (CAMPS) trial, an investigator initiated trial
L Mbuagbaw, L Thabane, P Ongolo-Zogo, T Lang
Trials 12, 1-7, 2011
872011
Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya
P Bejon, E Ogada, T Mwangi, P Milligan, T Lang, G Fegan, SC Gilbert, ...
PLoS One 2 (8), e707, 2007
872007
Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform
S Treweek, DG Altman, P Bower, M Campbell, I Chalmers, S Cotton, ...
Trials 16, 1-10, 2015
842015
The system can't perform the operation now. Try again later.
Articles 1–20